An Overview on Diabetis Mellitus

Authors

  • Hrishabh Jangid Department of Pharmaceutics, Kota College of Pharmacy, Kota, Rajasthan, India
  • Saurabh Chaturvedi Department of Pharmaceutics, Kota College of Pharmacy, Kota, Rajasthan, India
  • M. P. Khinchi Department of Pharmaceutics, Kota College of Pharmacy, Kota, Rajasthan, India

Keywords:

metabolic disease, hyperglycemia, insulin, neutral protamine hagedorn (NPH) insulin, Metformin

Abstract

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Diabetes is due to either the pancreas not producing enough insulin or the cells of the body not responding properly to the insulin produced. Symptoms of marked hyperglycemia include polyuria, polydipsia, weight loss, sometimes with polyphagia, and blurred vision. Diabetes is a more variable disease than once thought and people may have combinations of forms. There is no known preventive measure for type 1 diabetes. Type 2 diabetes, which accounts for 85-90% of all cases - can often be prevented or delayed by maintaining a normal body weight, engaging in physical exercise, and consuming a healthful diet. Type 1 diabetes can only be treated with insulin, typically with a combination of regular and NPH insulin, or synthetic insulin analogs. Metformin is generally recommended as a first line treatment for type 2 diabetes, as there is good evidence that it decreases mortality.

Downloads

Download data is not yet available.

Published

2017-05-01

How to Cite

Jangid, H., Chaturvedi, S., & Khinchi, M. P. (2017). An Overview on Diabetis Mellitus. Asian Journal of Pharmaceutical Research and Development, 5(3), 1–11. Retrieved from https://www.ajprd.com/index.php/journal/article/view/302

Issue

Section

Review Articles

Most read articles by the same author(s)

1 2 3 4 > >>